Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood

Shock

Volumn 16, Issue 3, 2001, Pages 178-182

  Wang, Jacob E ^a   Jørgensen, Pål F ^a   Ellingsen, Espen A ^a,b   Almlöf, Mia ^a,b   Thiemermann, Christoph ^c   Foster, Simon J ^d   Aasen, Ansgar O ^a   Solberg, Rigmor ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

IL 10; IL 6; Mixed bacterial infections; Sepsis; Tnf

Indexed keywords

CD14 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; SEPSIS;

ANTIGENS, CD14; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0040970359     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116030-00002     Document Type: Article

References (38)

1. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR: The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 92:10359-10363, 1995.
2. Kengatharan KM, De Kimpe S, Robson C, Foster SJ, Thiemermann C: Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential for the induction of nitric oxide synthase, shock and multiple organ failure. J Exp Med 188:305-315, 1998.
3. Wray GM, Foster SJ, Hinds CJ, Thiemermann C: A cell wall componenet from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumor necrosis factorα, nitric oxide production, shock and multiple organ injury/dysfunction in the rat. Shock (in press), 2000.
4. Bhakdi S, Klonisch T, Nuber P, Fischer W: Stimulation of monokine production by lipoteichoic acids. Infect Immunol 59:4614-4620, 1991.
5. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H: Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-α, interleukin-β and interleukin-6. FEMS Immunol Med Microbiol 7:281-287, 1993.
6. Wang JE, Jørgensen PF, Almlöf M, Thiemermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce TNFα, IL-6 and IL-10 production in both T-cells and monocytes in a whole human blood model. Infect Immunol 68:3965-3970, 2000.
7. Dziarski R, Tapping R, Tobias PS: Binding of bacterial peptidoglycan to CD14. J Biol Chem 273:8680-8690, 1998.
8. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R: CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 271:23310-23316, 1996.
9. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431-1433, 1990.
10. Kirschning CJ, Wesche H, Merrill AT, Rothe M: Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 178:2091-2097, 1998.
11. Schwander R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274:17406-17409, 1999.
12. Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395:284-288, 1998.
13. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J Immunol 163:1-5, 1999.
14. Schirmer WJ, Schinner JM, Fry DE: Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 124:445-448, 1989.
15. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey III TJ, Zentella A, Albert JD, et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
16. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, et al.: Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211-1227, 1988
17. Van der Poll T, van Deventer SJ, Buller HR, Sturk A, ten Cate JW: Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healty humans. Prog Clin Biol Res 367:55-60, 1991.
18. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987.
19. De Waal Malefyt R, Adams J, Bennett B, Figdor CG, De Bries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
20. Brandzaeg P, Osnes L, Øvstebø R, Joø GB, Westvik ÅB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184:51-60, 1996.
21. Waage A, Brandzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin-1, and fatal outcome. J Exp Med 169:333-338, 1989.
22. Foster SJ: Analysis of the autolysins of Bacillus subtilis 168 during vegetative growth and differentiation by using renaturing polyacrylamide gel electrophoresis. J Bacteriol 174:464-470, 1992.
23. Atrih A, Zöllner P, Allmaier G, Foster SJ: Structural analysis of Bacillus subtilis 168 endospore peptidoglycan and its role during differentiation. J Bacteriol 178:6173-6183, 1996.
24. Wang JE, Solberg R, Okkenhaug C, Jørgensen PF, Krohn CD, Aasen AO: Cytokine modulation in experimental endotoxemia: characterisation of an ex vivo whole blood model. Eur Surg Res 32:65-73, 2000.
25. Espevik T and Nissen-Meyer J: A highly sensitive cell line, WEHI clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
26. Polterak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998.
27. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takade H, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451, 1999.
28. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT: Toll-like receptor 4 imparts ligand specific recognition of bacterial lipopolysaccharide. J Clin Investig 105:497-504, 2000.
29. Flo TH, Halaas Ø, Lien E, Ryan L, Teti G, Golenbock DT, Sundan A, Espevik T: Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogeneses, but not by group B streptococci or lipopolysaccharide. J Immunol 164:2064-2069, 2000.
30. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bazil V, Kusumoto S, Flad H-D, Ulmer AJ: Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immunol 62:4709-4715, 1994.
31. Timmerman CP, Mattsson E, Martinez-Martinez L, de Graaf L, van Strijp JAG, Verbrugh HA, Verhoef J, Fleer A.: Induction of release of tumor necrosis factor from human monocytes by Staphylococci and Staphylococcal peptidoglycans. Infect Immunol 61:4167-4172, 1993.
32. Moreillon P, Majcherczyk P: Immunostimulation by peptidoglycan breakdown products from gram-positive bacteria. SHOCK (abstract 354) 13(suppl):90, 2000.
33. Haziot A, Hijiya N, Schultz K, Zhang F, Gangloff SC, Goyert SM: CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-α production. J Immunol 162:4801-4805, 1999.
34. Blank C, Luz A, Bendigs S, Erdmann A, Wagner H, Heeg K: Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol 27:825-833, 1997.
35. Weinstein MP, Murphy JR, Lichtenstein KA: The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Rev Inf Dis 5:54-70, 1983.
36. Cohen J, Abraham E: Microbiological findings and correlations with serum tumor necrosis factor-α in patients with severe sepsis and septic shock. J Infect Dis 180:116-121, 1999.
37. Koo DJ, Chaudry IH, Wang P: Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J Surg Res 83:151-157, 1999.
38. Lichtman SN, Wang J, Schwab JH, Lemasters JJ: Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kuppfer cells to produce tumor necrosis factor and interleukin-1. Hepatology 19:1013-1022, 1993.